Literature DB >> 16731609

Positive immunostaining for thyroid transcription factor-1 in primary and metastatic colonic adenocarcinoma: a note of caution.

D Penman1, I Downie, F Roberts.   

Abstract

Immunohistochemistry for thyroid transcription factor-1 (TTF-1) is considered an important ancillary technique for distinguishing primary pulmonary adenocarcinomas from metastases. A case of metastatic colonic adenocarcinoma in a bronchial biopsy specimen that showed focal positive nuclear staining for TTF-1 is reported here. The primary colonic adenocarcinoma was retrieved from the file and immunostaining also showed focal nuclear positivity for TTF-1. This confirmed the morphological and clinical impression of colonic metastases in the bronchial biopsy specimen. To investigate this apparent aberrant TTF-1 expression, further sections from primary colonic adenocarcinoma were immunostained for TTF-1 using the SPT24 antibody clone. Three of the six cases studied showed focal nuclear positivity with the SPT24 clone. All six cases were subsequently shown to be negative with the 8G7G1 clone. It is concluded that the SPT24 antibody to TTF-1 may show focal nuclear positivity in adenocarcinomas of colorectal origin such that focal staining in small biopsy specimens should be interpreted with caution.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16731609      PMCID: PMC1860399          DOI: 10.1136/jcp.2005.030064

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  7 in total

1.  Variable sensitivity and specificity of TTF-1 antibodies in lung metastatic adenocarcinoma of colorectal origin.

Authors:  Eva Compérat; Fan Zhang; Cedric Perrotin; Thierry Molina; Pierre Magdeleinat; Beatrice Marmey; Jean-Francois Régnard; Josee Audouin; Saphie Camilleri-Broët
Journal:  Mod Pathol       Date:  2005-10       Impact factor: 7.842

2.  Thyroid transcription factor-1, thyroglobulin, cytokeratin 7, and cytokeratin 20 in thyroid neoplasms.

Authors:  P A Bejarano; Y E Nikiforov; E S Swenson; P W Biddinger
Journal:  Appl Immunohistochem Mol Morphol       Date:  2000-09

3.  Surfactant proteins and thyroid transcription factor-1 in pulmonary and breast carcinomas.

Authors:  P A Bejarano; R P Baughman; P W Biddinger; M A Miller; C Fenoglio-Preiser; B al-Kafaji; R Di Lauro; J A Whitsett
Journal:  Mod Pathol       Date:  1996-04       Impact factor: 7.842

4.  Expression of TTF-1 and cytokeratins in primary and secondary epithelial lung tumours: correlation with histological type and grade.

Authors:  V Jerome Marson; J Mazieres; O Groussard; O Garcia; J Berjaud; M Dahan; P Carles; G Daste
Journal:  Histopathology       Date:  2004-08       Impact factor: 5.087

5.  The immunohistochemical diagnosis of mesothelioma: a comparative study of epithelioid mesothelioma and lung adenocarcinoma.

Authors:  Nelson G Ordóñez
Journal:  Am J Surg Pathol       Date:  2003-08       Impact factor: 6.394

6.  Thyroid transcription factor 1 in pulmonary adenocarcinoma.

Authors:  G Stenhouse; N Fyfe; G King; A Chapman; K M Kerr
Journal:  J Clin Pathol       Date:  2004-04       Impact factor: 3.411

7.  The role of TTF-1 in differentiating primary and metastatic lung adenocarcinomas.

Authors:  Judit Moldvay; M Jackel; K Bogos; I Soltész; L Agócs; G Kovács; Zsuzsa Schaff
Journal:  Pathol Oncol Res       Date:  2004-06-09       Impact factor: 2.874

  7 in total
  11 in total

1.  Thyroid transcription factor-1 may be expressed in ductal adenocarcinoma of the prostate:a potential pitfall.

Authors:  Tony Kiat-Hon Lim; Clarence Teo; Danilo M Giron; Yew-Lam Chong; Christopher Cheng; Puay-Hoon Tan
Journal:  J Clin Pathol       Date:  2007-08       Impact factor: 3.411

2.  TTF-1 staining in glioblastoma multiforme.

Authors:  Malcolm Galloway; Rosalind Sim
Journal:  Virchows Arch       Date:  2007-06-12       Impact factor: 4.064

3.  Thyroid transcription factor-1 expression in invasive and non-invasive urothelial carcinomas.

Authors:  S Sotiriou; N Koletsas; T Koletsa; S Touloupidis; M Lambropoulou
Journal:  Hippokratia       Date:  2017 Jul-Sep       Impact factor: 0.471

4.  [TTF-1 (8G7G3/1) positive colon adenocarcinoma: diagnostic implications].

Authors:  H G Reis; C H D Metz; H A Baba; N Bornfeld; K W Schmid; K A Metz
Journal:  Pathologe       Date:  2011-07       Impact factor: 1.011

5.  Malignant pure pulmonary ground-glass opacity nodules: prognostic implications.

Authors:  Jong Heon Park; Kyung Soo Lee; Ji Hye Kim; Young Mog Shim; Jhingook Kim; Yong Soo Choi; Chin A Yi
Journal:  Korean J Radiol       Date:  2009 Jan-Feb       Impact factor: 3.500

6.  Comparison of thyroid transcription factor-1 expression by 2 monoclonal antibodies in pulmonary and nonpulmonary primary tumors.

Authors:  Andres Matoso; Kamaljeet Singh; Rafik Jacob; Wesley O Greaves; Rosemarie Tavares; Lelia Noble; Murray B Resnick; Ronald A Delellis; Li J Wang
Journal:  Appl Immunohistochem Mol Morphol       Date:  2010-03

7.  Small cell neuroendocrine carcinoma of the endometrium with pulmonary metastasis: A clinicopathologic study of a case and a brief review of the literature.

Authors:  Antonio D'Antonio; Maria Addesso; Alessia Caleo; Maurizio Guida; Pio Zeppa
Journal:  Ann Med Surg (Lond)       Date:  2015-12-23

8.  TTF-1 Expression in Rectal Adenocarcinoma: A Case Report and Review of the Literature.

Authors:  Astrid Belalcazar; Uma Krishnamurti; Walid Shaib
Journal:  Case Rep Oncol       Date:  2016-11-18

9.  Targeted sequencing may facilitate differential diagnostics of pulmonary tumours: a case series.

Authors:  Kajsa Ericson-Lindquist; Anna Johansson; Per Levéen; Göran Elmberger; Göran Jönsson; Johan Staaf; Hans Brunnström
Journal:  Diagn Pathol       Date:  2017-03-27       Impact factor: 2.644

10.  Positive TTF-1 Expression in Malignant Mesothelioma: A Case Report.

Authors:  Georg Richter; Holger Heidersdorf; Dieter Hirschfeld; Friedhelm Krebbel
Journal:  Am J Case Rep       Date:  2016-03-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.